| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 3.15e-12 | 5 | 102 | 5 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 1.88e-11 | 6 | 102 | 5 | GO:0016160 | |
| GeneOntologyMolecularFunction | chloride ion binding | 1.18e-10 | 16 | 102 | 6 | GO:0031404 | |
| GeneOntologyMolecularFunction | fibroblast growth factor receptor activity | 1.28e-06 | 5 | 102 | 3 | GO:0005007 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | TBX22 FOSB BACH2 SREBF1 NR4A1 FOXA3 ZBTB24 HOXA1 HOXA6 OTX1 HOXD3 HOXD13 ASCL2 ZNF644 ZNF283 RORA RORC TAL1 | 5.41e-05 | 1244 | 102 | 18 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | TBX22 FOSB BACH2 SREBF1 NR4A1 FOXA3 ZBTB24 HOXA1 HOXA6 OTX1 HOXD3 HOXD13 ASCL2 ZNF644 ZNF283 RORA RORC TAL1 | 7.13e-05 | 1271 | 102 | 18 | GO:0000987 |
| GeneOntologyMolecularFunction | signaling receptor complex adaptor activity | 1.67e-04 | 54 | 102 | 4 | GO:0030159 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 1.86e-04 | 103 | 102 | 5 | GO:0004553 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 2.51e-04 | 60 | 102 | 4 | GO:0004879 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | TBX22 FOSB BACH2 SREBF1 NR4A1 FOXA3 ZBTB24 HOXA1 HOXA6 OTX1 HOXD3 HOXD13 ASCL2 ZNF644 ZNF283 RORA RORC TAL1 | 2.66e-04 | 1412 | 102 | 18 | GO:0000981 |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 2.68e-04 | 61 | 102 | 4 | GO:0098531 | |
| GeneOntologyMolecularFunction | fibroblast growth factor binding | 3.46e-04 | 27 | 102 | 3 | GO:0017134 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | TBX22 FOSB BACH2 SREBF1 NR4A1 FOXA3 ZBTB24 HOXA1 HOXA6 OTX1 HOXD3 HOXD13 ASCL2 ZNF644 ZNF283 RORA RORC TAL1 | 3.96e-04 | 1459 | 102 | 18 | GO:0000977 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 8.65e-04 | 144 | 102 | 5 | GO:0016798 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase activator activity | 9.09e-04 | 9 | 102 | 2 | GO:0141038 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 1.38e-03 | 43 | 102 | 3 | GO:0043548 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 2.39e-03 | 52 | 102 | 3 | GO:0042169 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.80e-03 | 188 | 102 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | oxysterol binding | 2.96e-03 | 16 | 102 | 2 | GO:0008142 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | ASXL1 ARHGAP32 RELN PPP1R9A OBSL1 LAMA3 LAMB1 REG1B PDZD7 ADD1 HOXA1 HMCN2 PTPRM FGD4 UNC5C AUTS2 FGFR2 TAL1 | 2.37e-05 | 1194 | 103 | 18 | GO:0000902 |
| GeneOntologyBiologicalProcess | fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development | 2.47e-05 | 2 | 103 | 2 | GO:0035607 | |
| GeneOntologyBiologicalProcess | Wnt receptor catabolic process | 2.47e-05 | 2 | 103 | 2 | GO:0038018 | |
| GeneOntologyBiologicalProcess | positive regulation of mesenchymal cell proliferation | 3.05e-05 | 36 | 103 | 4 | GO:0002053 | |
| GeneOntologyBiologicalProcess | regulation of glycogen biosynthetic process | 3.80e-05 | 38 | 103 | 4 | GO:0005979 | |
| GeneOntologyBiologicalProcess | regulation of glucan biosynthetic process | 3.80e-05 | 38 | 103 | 4 | GO:0010962 | |
| GeneOntologyBiologicalProcess | regulation of fibroblast growth factor production | 4.23e-05 | 14 | 103 | 3 | GO:0090270 | |
| GeneOntologyBiologicalProcess | fibroblast growth factor production | 4.23e-05 | 14 | 103 | 3 | GO:0090269 | |
| GeneOntologyBiologicalProcess | ventricular zone neuroblast division | 7.38e-05 | 3 | 103 | 2 | GO:0021847 | |
| GeneOntologyBiologicalProcess | orbitofrontal cortex development | 7.38e-05 | 3 | 103 | 2 | GO:0021769 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell proliferation | 7.47e-05 | 45 | 103 | 4 | GO:0010464 | |
| GeneOntologyBiologicalProcess | regulation of polysaccharide biosynthetic process | 8.87e-05 | 47 | 103 | 4 | GO:0032885 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ARHGAP32 RELN PPP1R9A OBSL1 LAMA3 LAMB1 PDZD7 HOXA1 HMCN2 PTPRM UNC5C AUTS2 FGFR2 | 8.96e-05 | 748 | 103 | 13 | GO:0048667 |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | AMY1A AMY1B AMY1C AMY2A AMY2B IRS1 PPP1R3A PASK PRKAA1 RORA RORC IRS2 | 9.13e-05 | 646 | 103 | 12 | GO:0005975 |
| GeneOntologyBiologicalProcess | regulation of glycogen metabolic process | 1.05e-04 | 49 | 103 | 4 | GO:0070873 | |
| GeneOntologyBiologicalProcess | positive regulation of parathyroid hormone secretion | 1.47e-04 | 4 | 103 | 2 | GO:2000830 | |
| GeneOntologyBiologicalProcess | regulation of synaptic activity | 1.47e-04 | 4 | 103 | 2 | GO:0060025 | |
| GeneOntologyBiologicalProcess | regulation of type B pancreatic cell proliferation | 1.51e-04 | 21 | 103 | 3 | GO:0061469 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 1.61e-04 | 231 | 103 | 7 | GO:0006109 | |
| GeneOntologyBiologicalProcess | glucan biosynthetic process | 1.64e-04 | 55 | 103 | 4 | GO:0009250 | |
| GeneOntologyBiologicalProcess | glycogen biosynthetic process | 1.64e-04 | 55 | 103 | 4 | GO:0005978 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ARHGAP32 RELN PPP1R9A OBSL1 LAMA3 LAMB1 REG1B HOXA1 HMCN2 PTPRM UNC5C AUTS2 FGFR2 | 1.79e-04 | 802 | 103 | 13 | GO:0048812 |
| GeneOntologyBiologicalProcess | regulation of polysaccharide metabolic process | 2.02e-04 | 58 | 103 | 4 | GO:0032881 | |
| GeneOntologyBiologicalProcess | mesenchymal cell proliferation | 2.16e-04 | 59 | 103 | 4 | GO:0010463 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ARHGAP32 RELN PPP1R9A OBSL1 LAMA3 LAMB1 REG1B HOXA1 HMCN2 PTPRM UNC5C AUTS2 FGFR2 | 2.19e-04 | 819 | 103 | 13 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ARHGAP32 RELN PPP1R9A OBSL1 LAMA3 LAMB1 REG1B HOXA1 HMCN2 PTPRM UNC5C AUTS2 FGFR2 | 2.38e-04 | 826 | 103 | 13 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of parathyroid hormone secretion | 2.45e-04 | 5 | 103 | 2 | GO:2000828 | |
| GeneOntologyBiologicalProcess | pattern specification process | 3.02e-04 | 526 | 103 | 10 | GO:0007389 | |
| GeneOntologyBiologicalProcess | forebrain ventricular zone progenitor cell division | 3.66e-04 | 6 | 103 | 2 | GO:0021869 | |
| GeneOntologyBiologicalProcess | response to lipid | SELE ASXL1 SASH1 FOSB SREBF1 IRS1 NR4A1 ADD1 HOXA1 HOXD13 PRKAA1 RORA RORC FGFR2 FGFR4 | 4.63e-04 | 1126 | 103 | 15 | GO:0033993 |
| GeneOntologyBiologicalProcess | inner ear morphogenesis | 4.75e-04 | 129 | 103 | 5 | GO:0042472 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ASXL1 FOSB TMPRSS6 SREBF1 NR4A1 FOXA3 HOXA1 OTX1 HOXD3 HOXD13 ASCL2 SKAP1 AUTS2 RORA FGFR1 FGFR2 TAL1 | 5.03e-04 | 1390 | 103 | 17 | GO:0045944 |
| GeneOntologyBiologicalProcess | response to retinoic acid | 5.09e-04 | 131 | 103 | 5 | GO:0032526 | |
| GeneOntologyBiologicalProcess | cerebral cortex tangential migration | 5.10e-04 | 7 | 103 | 2 | GO:0021800 | |
| GeneOntologyBiologicalProcess | forebrain neuroblast division | 5.10e-04 | 7 | 103 | 2 | GO:0021873 | |
| GeneOntologyBiologicalProcess | prostate glandular acinus morphogenesis | 5.10e-04 | 7 | 103 | 2 | GO:0060526 | |
| GeneOntologyBiologicalProcess | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis | 5.10e-04 | 7 | 103 | 2 | GO:0060527 | |
| GeneOntologyBiologicalProcess | parathyroid hormone secretion | 5.10e-04 | 7 | 103 | 2 | GO:0035898 | |
| GeneOntologyBiologicalProcess | axonogenesis | ARHGAP32 RELN LAMA3 LAMB1 HOXA1 HMCN2 PTPRM UNC5C AUTS2 FGFR2 | 5.36e-04 | 566 | 103 | 10 | GO:0007409 |
| GeneOntologyBiologicalProcess | polysaccharide biosynthetic process | 5.71e-04 | 76 | 103 | 4 | GO:0000271 | |
| GeneOntologyBiologicalProcess | axon guidance | 5.72e-04 | 285 | 103 | 7 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 5.84e-04 | 286 | 103 | 7 | GO:0097485 | |
| GeneOntologyBiologicalProcess | regulation of steroid metabolic process | 5.84e-04 | 135 | 103 | 5 | GO:0019218 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 5.97e-04 | 376 | 103 | 8 | GO:0008202 | |
| GeneOntologyBiologicalProcess | neuron projection development | ARHGAP32 RELN PPP1R9A OBSL1 LAMA3 LAMB1 MPDZ REG1B PDZD7 HOXA1 HMCN2 PTPRM UNC5C AUTS2 FGFR1 FGFR2 | 6.18e-04 | 1285 | 103 | 16 | GO:0031175 |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 6.47e-04 | 34 | 103 | 3 | GO:0097107 | |
| GeneOntologyBiologicalProcess | regionalization | 6.54e-04 | 478 | 103 | 9 | GO:0003002 | |
| GeneOntologyBiologicalProcess | head development | RELN SCHIP1 LAMB1 HOXA1 OTX1 KCNC2 UNC5C RORA GNB4 IRS2 FGFR1 FGFR2 SEZ6L | 6.56e-04 | 919 | 103 | 13 | GO:0060322 |
| GeneOntologyBiologicalProcess | positive regulation of type B pancreatic cell proliferation | 6.78e-04 | 8 | 103 | 2 | GO:1904692 | |
| GeneOntologyBiologicalProcess | negative regulation of fibroblast growth factor production | 6.78e-04 | 8 | 103 | 2 | GO:0090272 | |
| GeneOntologyBiologicalProcess | mesodermal cell differentiation | 7.05e-04 | 35 | 103 | 3 | GO:0048333 | |
| GeneOntologyBiologicalProcess | vitamin D3 metabolic process | 8.69e-04 | 9 | 103 | 2 | GO:0070640 | |
| GeneOntologyBiologicalProcess | neuron development | ARHGAP32 RELN PPP1R9A OBSL1 LAMA3 LAMB1 MPDZ REG1B PDZD7 HOXA1 HMCN2 PTPRM RP1L1 UNC5C AUTS2 FGFR1 FGFR2 | 8.94e-04 | 1463 | 103 | 17 | GO:0048666 |
| GeneOntologyBiologicalProcess | type B pancreatic cell proliferation | 9.70e-04 | 39 | 103 | 3 | GO:0044342 | |
| GeneOntologyBiologicalProcess | ear morphogenesis | 1.06e-03 | 154 | 103 | 5 | GO:0042471 | |
| GeneOntologyBiologicalProcess | regulation of glucagon secretion | 1.08e-03 | 10 | 103 | 2 | GO:0070092 | |
| GeneOntologyBiologicalProcess | glucagon secretion | 1.08e-03 | 10 | 103 | 2 | GO:0070091 | |
| GeneOntologyBiologicalProcess | regulation of phosphate transport | 1.08e-03 | 10 | 103 | 2 | GO:0010966 | |
| GeneOntologyBiologicalProcess | outer ear morphogenesis | 1.08e-03 | 10 | 103 | 2 | GO:0042473 | |
| GeneOntologyBiologicalProcess | lung-associated mesenchyme development | 1.08e-03 | 10 | 103 | 2 | GO:0060484 | |
| GeneOntologyBiologicalProcess | specification of animal organ identity | 1.12e-03 | 41 | 103 | 3 | GO:0010092 | |
| GeneOntologyBiologicalProcess | brain development | RELN LAMB1 HOXA1 OTX1 KCNC2 UNC5C RORA GNB4 IRS2 FGFR1 FGFR2 SEZ6L | 1.19e-03 | 859 | 103 | 12 | GO:0007420 |
| GeneOntologyBiologicalProcess | hormone secretion | 1.22e-03 | 420 | 103 | 8 | GO:0046879 | |
| GeneOntologyCellularComponent | chromatin | TBX22 CHAF1B FOSB BACH2 SREBF1 NR4A1 FOXA3 FAM111B HOXA1 HOXA6 OTX1 HOXD3 HOXD13 CBX6 ASCL2 PRKAA1 RORA RORC TAF5L TAL1 | 3.12e-05 | 1480 | 103 | 20 | GO:0000785 |
| GeneOntologyCellularComponent | lamellipodium | 1.44e-04 | 230 | 103 | 7 | GO:0030027 | |
| HumanPheno | Broad distal phalanx of the hallux | 6.89e-07 | 3 | 46 | 3 | HP:0010077 | |
| HumanPheno | Short middle phalanx of toe | 6.81e-06 | 5 | 46 | 3 | HP:0003795 | |
| HumanPheno | Broad distal phalanx of the toes | 6.81e-06 | 5 | 46 | 3 | HP:0010186 | |
| HumanPheno | Broad proximal phalanx of the hallux | 7.98e-05 | 2 | 46 | 2 | HP:0010086 | |
| HumanPheno | Calcaneonavicular fusion | 7.98e-05 | 2 | 46 | 2 | HP:0008122 | |
| HumanPheno | 3-4 toe cutaneous syndactyly | 7.98e-05 | 2 | 46 | 2 | HP:6000648 | |
| HumanPheno | Broad middle phalanges of the toes | 7.98e-05 | 2 | 46 | 2 | HP:0010195 | |
| HumanPheno | Tracheal cartilaginous sleeve | 7.98e-05 | 2 | 46 | 2 | HP:0005347 | |
| HumanPheno | Abnormality of the middle phalanges of the toes | 1.08e-04 | 11 | 46 | 3 | HP:0010183 | |
| HumanPheno | Abnormality of the distal phalanx of the hallux | 1.43e-04 | 12 | 46 | 3 | HP:0010053 | |
| HumanPheno | Angular cheilitis | 1.43e-04 | 12 | 46 | 3 | HP:0030318 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the hallux | 1.85e-04 | 13 | 46 | 3 | HP:0010058 | |
| MousePheno | ectopic Purkinje cell | 1.56e-05 | 26 | 83 | 4 | MP:0000885 | |
| MousePheno | premature facial suture closure | 3.48e-05 | 2 | 83 | 2 | MP:0030390 | |
| Domain | Aamy_C | 7.43e-10 | 4 | 99 | 4 | SM00632 | |
| Domain | Alpha_amylase | 7.43e-10 | 4 | 99 | 4 | IPR006046 | |
| Domain | Alpha-amylase_C | 3.70e-09 | 5 | 99 | 4 | PF02806 | |
| Domain | A-amylase/branching_C | 3.70e-09 | 5 | 99 | 4 | IPR006048 | |
| Domain | Aamy | 2.57e-08 | 7 | 99 | 4 | SM00642 | |
| Domain | Glyco_hydro_13_cat_dom | 2.57e-08 | 7 | 99 | 4 | IPR006047 | |
| Domain | Alpha-amylase | 2.57e-08 | 7 | 99 | 4 | PF00128 | |
| Domain | A-amylase_C | 1.44e-07 | 3 | 99 | 3 | IPR031319 | |
| Domain | FGF_rcpt_fam | 5.76e-07 | 4 | 99 | 3 | IPR016248 | |
| Domain | Glyco_hydro_b | 9.69e-07 | 15 | 99 | 4 | IPR013780 | |
| Domain | Glyco_hydro_13 | 2.86e-06 | 6 | 99 | 3 | IPR015902 | |
| Domain | CUB | 6.63e-06 | 50 | 99 | 5 | SM00042 | |
| Domain | - | 8.06e-06 | 52 | 99 | 5 | 2.60.120.290 | |
| Domain | CUB | 8.86e-06 | 53 | 99 | 5 | PS01180 | |
| Domain | CUB_dom | 1.27e-05 | 57 | 99 | 5 | IPR000859 | |
| Domain | Gprotein_B | 1.69e-05 | 10 | 99 | 3 | IPR001632 | |
| Domain | WD40_repeat_CS | 2.68e-05 | 164 | 99 | 7 | IPR019775 | |
| Domain | Glyco_hydro_catalytic_dom | 4.77e-05 | 38 | 99 | 4 | IPR013781 | |
| Domain | - | 5.04e-05 | 14 | 99 | 3 | 2.60.40.1180 | |
| Domain | ROR_rcpt | 8.32e-05 | 3 | 99 | 2 | IPR003079 | |
| Domain | CUB | 1.31e-04 | 49 | 99 | 4 | PF00431 | |
| Domain | Glycoside_hydrolase_SF | 1.78e-04 | 53 | 99 | 4 | IPR017853 | |
| Domain | ANTENNAPEDIA | 2.70e-04 | 24 | 99 | 3 | PS00032 | |
| Domain | Guanine_nucleotide-bd_bsu | 2.75e-04 | 5 | 99 | 2 | IPR016346 | |
| Domain | EGF-like_dom | 3.61e-04 | 249 | 99 | 7 | IPR000742 | |
| Domain | EGF_1 | 4.17e-04 | 255 | 99 | 7 | PS00022 | |
| Domain | WD40 | 4.58e-04 | 259 | 99 | 7 | PF00400 | |
| Domain | EGF-like_CS | 4.79e-04 | 261 | 99 | 7 | IPR013032 | |
| Domain | Ig_I-set | 5.24e-04 | 190 | 99 | 6 | IPR013098 | |
| Domain | I-set | 5.24e-04 | 190 | 99 | 6 | PF07679 | |
| Domain | EGF_2 | 5.24e-04 | 265 | 99 | 7 | PS01186 | |
| Domain | WD40 | 5.61e-04 | 268 | 99 | 7 | SM00320 | |
| Domain | WD40_repeat | 6.12e-04 | 272 | 99 | 7 | IPR001680 | |
| Domain | WD_REPEATS_1 | 6.96e-04 | 278 | 99 | 7 | PS00678 | |
| Domain | WD_REPEATS_2 | 7.11e-04 | 279 | 99 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 7.11e-04 | 279 | 99 | 7 | PS50294 | |
| Domain | - | 8.36e-04 | 35 | 99 | 3 | 3.20.20.80 | |
| Domain | WD40_repeat_dom | 1.02e-03 | 297 | 99 | 7 | IPR017986 | |
| Domain | G-protein_beta_WD-40_rep | 1.08e-03 | 85 | 99 | 4 | IPR020472 | |
| Domain | PTBI | 1.48e-03 | 11 | 99 | 2 | SM00310 | |
| Domain | IGc2 | 1.58e-03 | 235 | 99 | 6 | SM00408 | |
| Domain | Ig_sub2 | 1.58e-03 | 235 | 99 | 6 | IPR003598 | |
| Domain | EGF | 1.58e-03 | 235 | 99 | 6 | SM00181 | |
| Domain | IRS_PTB | 1.77e-03 | 12 | 99 | 2 | PS51064 | |
| Domain | IG | 1.79e-03 | 421 | 99 | 8 | SM00409 | |
| Domain | Ig_sub | 1.79e-03 | 421 | 99 | 8 | IPR003599 | |
| Domain | zf-C4 | 1.86e-03 | 46 | 99 | 3 | PF00105 | |
| Domain | Znf_hrmn_rcpt | 1.86e-03 | 46 | 99 | 3 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 1.86e-03 | 46 | 99 | 3 | IPR001723 | |
| Domain | NUCLEAR_REC_DBD_2 | 1.86e-03 | 46 | 99 | 3 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 1.86e-03 | 46 | 99 | 3 | PS00031 | |
| Domain | ZnF_C4 | 1.86e-03 | 46 | 99 | 3 | SM00399 | |
| Domain | - | 1.97e-03 | 333 | 99 | 7 | 2.130.10.10 | |
| Domain | - | 1.98e-03 | 47 | 99 | 3 | 1.10.565.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 2.04e-03 | 335 | 99 | 7 | IPR015943 | |
| Domain | HOLI | 2.10e-03 | 48 | 99 | 3 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 2.10e-03 | 48 | 99 | 3 | IPR000536 | |
| Domain | Hormone_recep | 2.10e-03 | 48 | 99 | 3 | PF00104 | |
| Domain | IRS_PTB | 2.43e-03 | 14 | 99 | 2 | IPR002404 | |
| Domain | IRS | 2.43e-03 | 14 | 99 | 2 | PF02174 | |
| Domain | Sushi | 2.64e-03 | 52 | 99 | 3 | PF00084 | |
| Domain | CCP | 2.95e-03 | 54 | 99 | 3 | SM00032 | |
| Domain | Homeobox_CS | 3.12e-03 | 186 | 99 | 5 | IPR017970 | |
| Domain | MAM_1 | 3.18e-03 | 16 | 99 | 2 | PS00740 | |
| Domain | Laminin_N | 3.18e-03 | 16 | 99 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 3.18e-03 | 16 | 99 | 2 | PS51117 | |
| Domain | Laminin_N | 3.18e-03 | 16 | 99 | 2 | PF00055 | |
| Domain | LamNT | 3.18e-03 | 16 | 99 | 2 | SM00136 | |
| Domain | SUSHI | 3.27e-03 | 56 | 99 | 3 | PS50923 | |
| Domain | ig | 3.42e-03 | 190 | 99 | 5 | PF00047 | |
| Domain | Immunoglobulin | 3.42e-03 | 190 | 99 | 5 | IPR013151 | |
| Domain | Sushi_SCR_CCP_dom | 3.44e-03 | 57 | 99 | 3 | IPR000436 | |
| Domain | - | 3.44e-03 | 57 | 99 | 3 | 3.30.50.10 | |
| Domain | MAM | 3.59e-03 | 17 | 99 | 2 | SM00137 | |
| Domain | Znf_NHR/GATA | 3.61e-03 | 58 | 99 | 3 | IPR013088 | |
| Domain | MAM | 4.03e-03 | 18 | 99 | 2 | PF00629 | |
| Domain | MAM_dom | 4.03e-03 | 18 | 99 | 2 | IPR000998 | |
| Domain | MAM_2 | 4.03e-03 | 18 | 99 | 2 | PS50060 | |
| Domain | IG_LIKE | 4.57e-03 | 491 | 99 | 8 | PS50835 | |
| Domain | Ig-like_dom | 5.27e-03 | 503 | 99 | 8 | IPR007110 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 4.02e-10 | 9 | 73 | 5 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.46e-09 | 11 | 73 | 5 | M1091 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | RELN SREBF1 LAMA3 LAMB1 IRS1 PRKAA1 GNB4 IRS2 FGFR1 FGFR2 FGFR4 GNB2 | 4.30e-08 | 302 | 73 | 12 | M39719 |
| Pathway | REACTOME_DIGESTION | 1.01e-07 | 23 | 73 | 5 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 2.90e-07 | 28 | 73 | 5 | M27837 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | RELN SREBF1 LAMA3 LAMB1 IRS1 PRKAA1 GNB4 IRS2 FGFR1 FGFR2 FGFR4 | 8.47e-07 | 326 | 73 | 11 | MM15917 |
| Pathway | WP_PI3KAKT_SIGNALING | RELN LAMA3 LAMB1 IRS1 SGK2 PRKAA1 GNB4 FGFR1 FGFR2 FGFR4 GNB2 | 1.24e-06 | 339 | 73 | 11 | M39736 |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 4.67e-06 | 48 | 73 | 5 | M26916 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 6.97e-06 | 52 | 73 | 5 | M14171 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 7.32e-06 | 8 | 73 | 3 | MM14717 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 8.41e-06 | 54 | 73 | 5 | M27168 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 8.41e-06 | 54 | 73 | 5 | M620 | |
| Pathway | REACTOME_PI3K_AKT_SIGNALING_IN_CANCER | 2.19e-05 | 110 | 73 | 6 | M27162 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 2.42e-05 | 33 | 73 | 4 | M39503 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 6.49e-05 | 82 | 73 | 5 | M1021 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER | 6.87e-05 | 83 | 73 | 5 | M27163 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 1.27e-04 | 50 | 73 | 4 | M48087 | |
| Pathway | WP_FOXA2_PATHWAY | 1.66e-04 | 21 | 73 | 3 | M42579 | |
| Pathway | REACTOME_DIGESTION | 1.66e-04 | 21 | 73 | 3 | MM15526 | |
| Pathway | REACTOME_IRS_ACTIVATION | 2.62e-04 | 5 | 73 | 2 | M27707 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 2.82e-04 | 25 | 73 | 3 | MM15557 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 2.82e-04 | 25 | 73 | 3 | M47934 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 3.60e-04 | 118 | 73 | 5 | M713 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 3.74e-04 | 66 | 73 | 4 | MM15925 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY | 5.40e-04 | 31 | 73 | 3 | M47396 | |
| Pathway | REACTOME_SOS_MEDIATED_SIGNALLING | 5.46e-04 | 7 | 73 | 2 | M19489 | |
| Pathway | WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME | 5.61e-04 | 130 | 73 | 5 | M39787 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 5.93e-04 | 32 | 73 | 3 | MM14983 | |
| Pathway | KEGG_INSULIN_SIGNALING_PATHWAY | 7.13e-04 | 137 | 73 | 5 | M18155 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY | 7.74e-04 | 35 | 73 | 3 | M47379 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 9.30e-04 | 9 | 73 | 2 | M47397 | |
| Pathway | REACTOME_PI3K_AKT_ACTIVATION | 9.30e-04 | 9 | 73 | 2 | M714 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 9.87e-04 | 38 | 73 | 3 | M39657 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 9.87e-04 | 38 | 73 | 3 | MM15865 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 1.16e-03 | 313 | 73 | 7 | M27867 | |
| Pathway | REACTOME_SIGNAL_ATTENUATION | 1.16e-03 | 10 | 73 | 2 | M14236 | |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 1.23e-03 | 41 | 73 | 3 | MM14505 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 1.32e-03 | 42 | 73 | 3 | M791 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 1.41e-03 | 11 | 73 | 2 | M27195 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.41e-03 | 11 | 73 | 2 | M158 | |
| Pathway | WP_INSULIN_SIGNALING | 1.43e-03 | 160 | 73 | 5 | M39482 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 1.66e-03 | 98 | 73 | 4 | M39830 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 1.83e-03 | 47 | 73 | 3 | MM14885 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 1.83e-03 | 47 | 73 | 3 | M19708 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 1.90e-03 | 439 | 73 | 8 | M42563 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 1.95e-03 | 48 | 73 | 3 | MM15441 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 1.95e-03 | 48 | 73 | 3 | MM14987 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 2.59e-03 | 53 | 73 | 3 | M8276 | |
| Pathway | WP_RAS_SIGNALING | 2.63e-03 | 184 | 73 | 5 | M39764 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 2.66e-03 | 15 | 73 | 2 | M47380 | |
| Pathway | PID_FGF_PATHWAY | 2.88e-03 | 55 | 73 | 3 | M276 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 2.88e-03 | 55 | 73 | 3 | M47952 | |
| Pathway | REACTOME_RHOJ_GTPASE_CYCLE | 3.03e-03 | 16 | 73 | 2 | MM15605 | |
| Pubmed | 1.30e-12 | 6 | 104 | 5 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 1.30e-12 | 6 | 104 | 5 | 2788608 | |
| Pubmed | 1.30e-12 | 6 | 104 | 5 | 15286789 | ||
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 1.30e-12 | 6 | 104 | 5 | 6608795 | |
| Pubmed | 1.30e-12 | 6 | 104 | 5 | 2081604 | ||
| Pubmed | Rostral cerebellar malformation, (rcm): a new recessive mutation on chromosome 3 of the mouse. | 4.53e-12 | 7 | 104 | 5 | 1401878 | |
| Pubmed | 1.21e-11 | 8 | 104 | 5 | 12414807 | ||
| Pubmed | 4.43e-11 | 22 | 104 | 6 | 11696558 | ||
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 7.54e-11 | 4 | 104 | 4 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 7.54e-11 | 4 | 104 | 4 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 7.54e-11 | 4 | 104 | 4 | 6166922 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 7.54e-11 | 4 | 104 | 4 | 26098870 | |
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 7.54e-11 | 4 | 104 | 4 | 4745489 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 7.54e-11 | 4 | 104 | 4 | 94264 | |
| Pubmed | 7.54e-11 | 4 | 104 | 4 | 3872721 | ||
| Pubmed | 7.54e-11 | 4 | 104 | 4 | 2476716 | ||
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 7.54e-11 | 4 | 104 | 4 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 7.54e-11 | 4 | 104 | 4 | 6163812 | |
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 7.54e-11 | 4 | 104 | 4 | 2987507 | |
| Pubmed | 7.54e-11 | 4 | 104 | 4 | 6091898 | ||
| Pubmed | 7.54e-11 | 4 | 104 | 4 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 7.54e-11 | 4 | 104 | 4 | 6162108 | |
| Pubmed | 7.54e-11 | 4 | 104 | 4 | 16152770 | ||
| Pubmed | 7.54e-11 | 4 | 104 | 4 | 2423416 | ||
| Pubmed | 7.54e-11 | 4 | 104 | 4 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 7.54e-11 | 4 | 104 | 4 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 7.54e-11 | 4 | 104 | 4 | 2989529 | |
| Pubmed | 7.54e-11 | 4 | 104 | 4 | 6160849 | ||
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 7.54e-11 | 4 | 104 | 4 | 1141004 | |
| Pubmed | 7.54e-11 | 4 | 104 | 4 | 6157477 | ||
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 7.54e-11 | 4 | 104 | 4 | 2431276 | |
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 7.54e-11 | 4 | 104 | 4 | 6207174 | |
| Pubmed | Expression of sulfated gp300 and changes in glycosylation during pancreatic development. | 7.54e-11 | 4 | 104 | 4 | 8543783 | |
| Pubmed | 7.54e-11 | 4 | 104 | 4 | 2410924 | ||
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 7.54e-11 | 4 | 104 | 4 | 2332419 | |
| Pubmed | 1.35e-10 | 26 | 104 | 6 | 7905852 | ||
| Pubmed | 3.76e-10 | 5 | 104 | 4 | 6529441 | ||
| Pubmed | 3.76e-10 | 5 | 104 | 4 | 6176569 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 3.76e-10 | 5 | 104 | 4 | 34276419 | |
| Pubmed | 3.76e-10 | 5 | 104 | 4 | 1348427 | ||
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 3.76e-10 | 5 | 104 | 4 | 8661735 | |
| Pubmed | 1.13e-09 | 6 | 104 | 4 | 2002257 | ||
| Pubmed | 1.13e-09 | 6 | 104 | 4 | 2450406 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 1.13e-09 | 6 | 104 | 4 | 2328996 | |
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 1.13e-09 | 6 | 104 | 4 | 284003 | |
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 1.13e-09 | 6 | 104 | 4 | 9250879 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 1.13e-09 | 6 | 104 | 4 | 7859283 | |
| Pubmed | 1.13e-09 | 6 | 104 | 4 | 7946325 | ||
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 1.13e-09 | 6 | 104 | 4 | 1021597 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TBX22 FOSB BACH2 SREBF1 NR4A1 FOXA3 ZBTB24 HOXA1 HOXA6 OTX1 HOXD3 HOXD13 ASCL2 ZNF644 RORA RORC TAL1 | 1.72e-09 | 908 | 104 | 17 | 19274049 |
| Pubmed | Analysis of the mouse Amy locus in recombinant inbred mouse strains. | 2.62e-09 | 7 | 104 | 4 | 2451911 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 7949740 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 6160178 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 8604219 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 8666240 | ||
| Pubmed | 2.71e-09 | 118 | 104 | 8 | 16971476 | ||
| Pubmed | 5.23e-09 | 8 | 104 | 4 | 2040456 | ||
| Pubmed | 5.23e-09 | 8 | 104 | 4 | 3038891 | ||
| Pubmed | 5.23e-09 | 8 | 104 | 4 | 8486361 | ||
| Pubmed | Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. | 5.23e-09 | 8 | 104 | 4 | 7523515 | |
| Pubmed | 5.23e-09 | 8 | 104 | 4 | 2824476 | ||
| Pubmed | 5.23e-09 | 8 | 104 | 4 | 15003629 | ||
| Pubmed | Linkage relationships among eleven biochemical loci in Peromyscus. | 5.23e-09 | 8 | 104 | 4 | 6200103 | |
| Pubmed | 5.25e-09 | 46 | 104 | 6 | 23684747 | ||
| Pubmed | 8.81e-09 | 24 | 104 | 5 | 22529374 | ||
| Pubmed | 9.40e-09 | 9 | 104 | 4 | 93520 | ||
| Pubmed | 1.56e-08 | 10 | 104 | 4 | 9121556 | ||
| Pubmed | 1.56e-08 | 10 | 104 | 4 | 2897103 | ||
| Pubmed | 2.45e-08 | 11 | 104 | 4 | 23449223 | ||
| Pubmed | 2.45e-08 | 11 | 104 | 4 | 7608209 | ||
| Pubmed | 2.45e-08 | 11 | 104 | 4 | 1617215 | ||
| Pubmed | 2.45e-08 | 11 | 104 | 4 | 2903254 | ||
| Pubmed | 2.45e-08 | 11 | 104 | 4 | 2565740 | ||
| Pubmed | Mouse R-cadherin: expression during the organogenesis of pancreas and gastrointestinal tract. | 2.45e-08 | 11 | 104 | 4 | 7493641 | |
| Pubmed | Four loci from human chromosome 1 are physically assigned to sheep chromosome 1p. | 2.45e-08 | 11 | 104 | 4 | 8589528 | |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 32697825 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 28056982 | ||
| Pubmed | The structure of two distinct pancreatic amylase genes in mouse strain YBR. | 2.60e-08 | 3 | 104 | 3 | 2413838 | |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 2.60e-08 | 3 | 104 | 3 | 21827821 | |
| Pubmed | Report of the Committee on the Genetic Constitution of Chromosome 1. | 2.60e-08 | 3 | 104 | 3 | 6360562 | |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 25349422 | ||
| Pubmed | Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice. | 2.60e-08 | 3 | 104 | 3 | 2436036 | |
| Pubmed | Two distinct pancreatic amylase genes are active in YBR mice. | 2.60e-08 | 3 | 104 | 3 | 6180955 | |
| Pubmed | Comparative genomic analysis of the mouse and rat amylase multigene family. | 2.60e-08 | 3 | 104 | 3 | 17223109 | |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 15299664 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 8413315 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 22063648 | ||
| Pubmed | An insulin-responsive element in the pancreatic enhancer of the amylase gene. | 2.60e-08 | 3 | 104 | 3 | 7678001 | |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 6098446 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 30982860 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 1699843 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 2165484 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 12527308 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 2414282 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 28659346 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 25588701 | ||
| Pubmed | 3.67e-08 | 12 | 104 | 4 | 11044404 | ||
| Pubmed | 3.67e-08 | 12 | 104 | 4 | 8144363 | ||
| Pubmed | 4.10e-08 | 32 | 104 | 5 | 25715394 | ||
| Interaction | FGF6 interactions | 4.34e-06 | 7 | 102 | 3 | int:FGF6 | |
| Interaction | FGF18 interactions | 4.34e-06 | 7 | 102 | 3 | int:FGF18 | |
| Interaction | FGF5 interactions | 6.92e-06 | 8 | 102 | 3 | int:FGF5 | |
| Interaction | FGF23 interactions | 6.92e-06 | 8 | 102 | 3 | int:FGF23 | |
| Interaction | AMY2B interactions | 1.47e-05 | 10 | 102 | 3 | int:AMY2B | |
| Interaction | HTN3 interactions | 1.53e-05 | 30 | 102 | 4 | int:HTN3 | |
| Interaction | RPS6KA1 interactions | 2.09e-05 | 228 | 102 | 8 | int:RPS6KA1 | |
| Interaction | TNS2 interactions | 2.59e-05 | 235 | 102 | 8 | int:TNS2 | |
| Interaction | KLB interactions | 2.68e-05 | 12 | 102 | 3 | int:KLB | |
| Interaction | ZNF843 interactions | 4.40e-05 | 14 | 102 | 3 | int:ZNF843 | |
| Interaction | KL interactions | 4.40e-05 | 14 | 102 | 3 | int:KL | |
| Interaction | PIK3R1 interactions | 4.57e-05 | 412 | 102 | 10 | int:PIK3R1 | |
| Interaction | FGF7 interactions | 6.72e-05 | 16 | 102 | 3 | int:FGF7 | |
| Interaction | FGF9 interactions | 6.72e-05 | 16 | 102 | 3 | int:FGF9 | |
| Interaction | FGF17 interactions | 7.19e-05 | 44 | 102 | 4 | int:FGF17 | |
| Interaction | DIP2A interactions | 1.28e-04 | 96 | 102 | 5 | int:DIP2A | |
| Cytoband | 1p21 | 2.22e-09 | 24 | 104 | 5 | 1p21 | |
| Cytoband | 7q22 | 1.73e-06 | 38 | 104 | 4 | 7q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 4.79e-06 | 107 | 104 | 5 | chr1p21 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.92e-06 | 161 | 70 | 7 | 593 | |
| GeneFamily | HOXL subclass homeoboxes | 4.85e-05 | 52 | 70 | 4 | 518 | |
| GeneFamily | WD repeat domain containing | 6.82e-05 | 262 | 70 | 7 | 362 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 4.96e-04 | 40 | 70 | 3 | 321 | |
| GeneFamily | Nuclear hormone receptors | 9.01e-04 | 49 | 70 | 3 | 71 | |
| GeneFamily | Laminin subunits | 9.51e-04 | 12 | 70 | 2 | 626 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.21e-03 | 206 | 70 | 5 | 682 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.40e-03 | 57 | 70 | 3 | 1179 | |
| GeneFamily | Basic helix-loop-helix proteins | 8.93e-03 | 110 | 70 | 3 | 420 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.10e-02 | 41 | 70 | 2 | 1298 | |
| GeneFamily | Basic leucine zipper proteins | 1.55e-02 | 49 | 70 | 2 | 506 | |
| Coexpression | IGLESIAS_E2F_TARGETS_DN | 6.72e-08 | 27 | 104 | 5 | MM643 | |
| Coexpression | BERGER_MBD2_TARGETS | 7.55e-08 | 11 | 104 | 4 | MM905 | |
| Coexpression | MCCLUNG_CREB1_TARGETS_DN | 4.10e-06 | 60 | 104 | 5 | MM654 | |
| Coexpression | BENPORATH_EED_TARGETS | TBX22 ASXL1 RELN BACH2 HOXA1 HOXA6 OTX1 HOXD3 KCNC2 HOXD13 ASCL2 UNC5C AUTS2 CACNA1G TAL1 | 1.86e-05 | 1059 | 104 | 15 | M7617 |
| Coexpression | LEE_AGING_MUSCLE_UP | 2.12e-05 | 41 | 104 | 4 | MM698 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | ARHGAP32 RELN SASH1 FOSB PPP1R9A LAMB1 MPDZ NR4A1 FOXA3 UNC5C RORA TAL1 | 2.94e-05 | 721 | 104 | 12 | M1999 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | RELN BACH2 PPP1R9A APC2 LAMA3 PDZD7 SYBU CSMD2 SGK2 KCNC2 AUTS2 RORA CACNA1G TAL1 SEZ6L | 3.08e-05 | 1106 | 104 | 15 | M39071 |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 7.65e-05 | 177 | 104 | 6 | M39245 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.79e-07 | 186 | 104 | 7 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.00e-07 | 188 | 104 | 7 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.34e-07 | 191 | 104 | 7 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.40e-07 | 199 | 104 | 7 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.51e-06 | 83 | 104 | 5 | 3aa95bf2d8ac37e648037faf3d54ebb243a4fde1 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.51e-06 | 83 | 104 | 5 | 70804dd63221dd5ed26068ec1b50f11875abbc50 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.51e-06 | 83 | 104 | 5 | c1818411438f53aec76afead5c8caab701b95d39 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.51e-06 | 83 | 104 | 5 | 1e7af8aaa20b4c2a77cf2f330113db0faa9d483c | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.62e-06 | 153 | 104 | 6 | 5501095bcf73080872ae01128f21399f9cfc5dd1 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-06 | 157 | 104 | 6 | a426c54fd1545093d41426e9620862f71bd06f6b | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.98e-06 | 170 | 104 | 6 | 6c65ddb496030bb479ef346cc37a9d4dfa6b824f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.01e-06 | 179 | 104 | 6 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Trm_Th1/Th17|GI_large-bowel / Manually curated celltypes from each tissue | 4.01e-06 | 179 | 104 | 6 | 6359f30005b17dc5b5c4c8f3a6a38c87ccfe4ee9 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 182 | 104 | 6 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 182 | 104 | 6 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.55e-06 | 183 | 104 | 6 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 5.47e-06 | 189 | 104 | 6 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.64e-06 | 190 | 104 | 6 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.64e-06 | 190 | 104 | 6 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.99e-06 | 192 | 104 | 6 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 6.17e-06 | 193 | 104 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 6.17e-06 | 193 | 104 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.35e-06 | 194 | 104 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.35e-06 | 194 | 104 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 6.35e-06 | 194 | 104 | 6 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.35e-06 | 194 | 104 | 6 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 6.54e-06 | 195 | 104 | 6 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.54e-06 | 195 | 104 | 6 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.54e-06 | 195 | 104 | 6 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.54e-06 | 195 | 104 | 6 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-06 | 196 | 104 | 6 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-06 | 196 | 104 | 6 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-06 | 196 | 104 | 6 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | 6.74e-06 | 196 | 104 | 6 | 96c6d78482a130ce4e29f6629972a06d10d7530e | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 6.94e-06 | 197 | 104 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 6.94e-06 | 197 | 104 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.14e-06 | 198 | 104 | 6 | 84697f316d9195ebe838cf57f4dbdd9feea43bec | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 7.14e-06 | 198 | 104 | 6 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.14e-06 | 198 | 104 | 6 | eda85a592527992b51a00f288cff0c3239c47e6f | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.14e-06 | 198 | 104 | 6 | b3a020522e064bb61949d38e442f24026e339364 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.14e-06 | 198 | 104 | 6 | fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 7.35e-06 | 199 | 104 | 6 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.35e-06 | 199 | 104 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.35e-06 | 199 | 104 | 6 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Transverse-(3)_ILC-(30)_ILC|Transverse / shred on region, Cell_type, and subtype | 7.56e-06 | 200 | 104 | 6 | 528520dc98775aca6cc7568fedf5906ea55e0bea | |
| ToppCell | Transverse-(3)_ILC|Transverse / shred on region, Cell_type, and subtype | 7.56e-06 | 200 | 104 | 6 | c1ad7cb012e1c8911e417f7d64ca662c4f5010e0 | |
| ToppCell | Transverse-ILC|Transverse / Region, Cell class and subclass | 7.56e-06 | 200 | 104 | 6 | eb04d6ad2270d3d9ac3d1fae1bb9bedc6fca38fe | |
| ToppCell | Transverse-ILC-ILC|Transverse / Region, Cell class and subclass | 7.56e-06 | 200 | 104 | 6 | 60ec185df2f1989bf8febf75b11c46a576829be3 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-MAIT|Leuk-UTI / Disease, condition lineage and cell class | 7.56e-06 | 200 | 104 | 6 | 7e0d0f051c197c2c70080f039e1c4dd68db8e74f | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 70 | 104 | 4 | 26178ee967d647224d93c7a6380f2d15d8fcfb8f | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 70 | 104 | 4 | 5720505ef03d65c73028616c808420e282823bde | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related-Oligodendrocyte/OPC|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.80e-05 | 151 | 104 | 5 | 4533bccc996395f74b16af939ce79b6fe253c073 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.80e-05 | 151 | 104 | 5 | edb2f59789c295838d2030b80c792cbea25eaa3d | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-05 | 151 | 104 | 5 | a306e8dac653bc785d805d8d2d94feec3cb01727 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 153 | 104 | 5 | 39ac25c48e73538f1c10f37bea386e0e88d3e8d0 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 3.18e-05 | 155 | 104 | 5 | 83430a64c2cb5ad29caa3dacba76c28dd204ac40 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.48e-05 | 158 | 104 | 5 | 0d4fe87fc7901dd5f9c004e91708a03cafdb4ad9 | |
| ToppCell | severe_COVID-19-NK_CD56bright|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.48e-05 | 158 | 104 | 5 | c2e8d96fc29aa2388b92b4fd81d2726e1f7a053f | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.48e-05 | 158 | 104 | 5 | de65af8d3b8514b17978155f31975e2347b75251 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.59e-05 | 159 | 104 | 5 | 7cda111bb98f1241989e49d490bdf51a712ea589 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Monocytes|Myeloid_cells / Location, Cell class and cell subclass | 4.04e-05 | 163 | 104 | 5 | 7d7f18e5c99be125e95bc180823430291b770d05 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.04e-05 | 163 | 104 | 5 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.16e-05 | 164 | 104 | 5 | 08819970174a3eb4eee8e1e675075828665b845e | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma-7|TCGA-Kidney / Sample_Type by Project: Shred V9 | 4.41e-05 | 166 | 104 | 5 | b545de32578047c9ca422354b8992f2d9c9e1cc7 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.54e-05 | 167 | 104 | 5 | b93103a868fba63a8910bffb690a6242b9252833 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.54e-05 | 167 | 104 | 5 | fcd583b1efd0ac883379982ea8e6c54f2c0be268 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.54e-05 | 167 | 104 | 5 | f6bc63138b7239211fa5f27a8dc799b6e022c0f8 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.54e-05 | 167 | 104 | 5 | 26cd8ee5e826e71eaf58d10a906543a6932fb3f9 | |
| ToppCell | BAL-Severe-cDC_5|Severe / Compartment, Disease Groups and Clusters | 4.67e-05 | 168 | 104 | 5 | 857a80c217a5513553460798a625612031bc7bb7 | |
| ToppCell | Influenza_Severe-gd_T|Influenza_Severe / Disease group and Cell class | 4.94e-05 | 170 | 104 | 5 | 59009c5a504ea8c6b4f6697299db219fd5edf7d6 | |
| ToppCell | primary_auditory_cortex_(A1C)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.22e-05 | 172 | 104 | 5 | 20ea9db009370aa6235365ce93e153eb5b28db94 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_ASCL1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.36e-05 | 173 | 104 | 5 | 2e35bf2b5534a289d93a09faae660f665c131062 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-05 | 173 | 104 | 5 | c62e3ffed55bbb00dcaef6da0aab8446f3f55085 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-05 | 173 | 104 | 5 | f612d4ea9ab8dcde475f4118bca3e49be786e7fa | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-MAIT|lymph-node_spleen / Manually curated celltypes from each tissue | 5.82e-05 | 176 | 104 | 5 | 25c197d3b39deffa4801a1d12cdb54320cbae509 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.82e-05 | 176 | 104 | 5 | 5d3b2395bb842eea39175f5af6a4c76527e2fc31 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 5.82e-05 | 176 | 104 | 5 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.98e-05 | 177 | 104 | 5 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | C_00|World / shred on cell type and cluster | 6.30e-05 | 179 | 104 | 5 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.30e-05 | 179 | 104 | 5 | a634ca46ffc394c5f5215fc5d8eae4a77819af9c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.30e-05 | 179 | 104 | 5 | ff678e2f33c914e3dd0f338ada25f506c3e3c980 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.30e-05 | 179 | 104 | 5 | 35f014b6e752626909d829c5ab9bb761c1f3e3dc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.64e-05 | 181 | 104 | 5 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.64e-05 | 181 | 104 | 5 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-05 | 182 | 104 | 5 | da3e9093cba791c7c282eb044656046252a32789 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-05 | 182 | 104 | 5 | ccfee33de0faebbe69099d4ff3c3971f6a708b99 | |
| ToppCell | severe_influenza-gd_T|severe_influenza / disease group, cell group and cell class (v2) | 6.82e-05 | 182 | 104 | 5 | b6b44c90af3f0c0dddb2b171087865d8c15a3973 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-05 | 183 | 104 | 5 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.00e-05 | 183 | 104 | 5 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-05 | 183 | 104 | 5 | b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.18e-05 | 184 | 104 | 5 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | Serous|World / shred by cell class for bronchial biopsy | 7.18e-05 | 184 | 104 | 5 | 09d0d1525c11dd326efd942684c03f79d992cf3b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.18e-05 | 184 | 104 | 5 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.37e-05 | 185 | 104 | 5 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.37e-05 | 185 | 104 | 5 | e29079ef09aee62c3e9756341db4e59ca9dbf7ac | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.37e-05 | 185 | 104 | 5 | af86e75096c1812ae27a78405355957ee8043d84 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.37e-05 | 185 | 104 | 5 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|World / Stress and Cell class | 7.37e-05 | 185 | 104 | 5 | b8cd94cf18308b514fc61557550225794ffd2860 | |
| ToppCell | facs-Large_Intestine-Distal-24m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.37e-05 | 185 | 104 | 5 | 2ecc4b76b3645b65c226c2298bff307cc6479172 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.56e-05 | 186 | 104 | 5 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| Computational | Genes in the cancer module 100. | RELN SCHIP1 WDR7 TRO APC2 NR4A1 CBX6 TMCC2 FGFR1 FGFR2 DMBT1 | 1.11e-04 | 544 | 57 | 11 | MODULE_100 |
| Computational | CNS genes. | RELN SCHIP1 WDR7 TRO APC2 NR4A1 CBX6 TMCC2 FGFR1 FGFR2 DMBT1 | 1.15e-04 | 546 | 57 | 11 | MODULE_137 |
| Computational | Ovary genes. | 1.23e-04 | 368 | 57 | 9 | MODULE_1 | |
| Computational | Genes in the cancer module 66. | RELN SCHIP1 WDR7 TRO APC2 NR4A1 CBX6 TMCC2 FGFR1 FGFR2 DMBT1 | 1.27e-04 | 552 | 57 | 11 | MODULE_66 |
| Drug | trestatin A | 6.14e-13 | 9 | 103 | 6 | CID003054994 | |
| Drug | R 623 | 1.03e-11 | 6 | 103 | 5 | CID003027594 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 1.03e-11 | 6 | 103 | 5 | CID003083414 | |
| Drug | dimethylaminomethylferrocene | 1.03e-11 | 6 | 103 | 5 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 1.03e-11 | 6 | 103 | 5 | CID000127364 | |
| Drug | CNP-G3 | 1.03e-11 | 6 | 103 | 5 | CID003082910 | |
| Drug | AC1L5BOU | 3.58e-11 | 7 | 103 | 5 | CID000174858 | |
| Drug | BG5P | 3.58e-11 | 7 | 103 | 5 | CID003082752 | |
| Drug | desethylaprophen | 9.52e-11 | 8 | 103 | 5 | CID000163919 | |
| Drug | azintamide | 9.52e-11 | 8 | 103 | 5 | CID000071105 | |
| Drug | alpha-maltosyl fluoride | 2.13e-10 | 9 | 103 | 5 | CID000194237 | |
| Drug | N-PMT | 3.95e-10 | 4 | 103 | 4 | CID000194224 | |
| Drug | AC1MQT4V | 3.95e-10 | 4 | 103 | 4 | CID003482066 | |
| Drug | SAIB-SG | 3.95e-10 | 4 | 103 | 4 | CID002735139 | |
| Drug | 2-nitropropyl acetate | 3.95e-10 | 4 | 103 | 4 | CID013573844 | |
| Drug | Dembrexine | 3.95e-10 | 4 | 103 | 4 | CID000072009 | |
| Drug | g lw | 3.95e-10 | 4 | 103 | 4 | CID000444139 | |
| Drug | beta-santalene | 3.95e-10 | 4 | 103 | 4 | CID000010534 | |
| Drug | AC1LAC07 | 4.25e-10 | 10 | 103 | 5 | CID000485275 | |
| Drug | Glc)4 | 4.25e-10 | 10 | 103 | 5 | CID000189098 | |
| Drug | Ro 20-0083 | 4.25e-10 | 10 | 103 | 5 | CID003082332 | |
| Drug | AC1L3M0Q | 4.25e-10 | 10 | 103 | 5 | CID000118008 | |
| Drug | validamycin D | 7.77e-10 | 11 | 103 | 5 | CID000166726 | |
| Drug | FG5P | 7.77e-10 | 11 | 103 | 5 | CID000127486 | |
| Drug | CNP-G5 | 7.77e-10 | 11 | 103 | 5 | CID000127309 | |
| Drug | HgI2 | 7.77e-10 | 11 | 103 | 5 | CID000024485 | |
| Drug | 2C KM | 7.77e-10 | 11 | 103 | 5 | CID009549196 | |
| Drug | azaprophen | 1.33e-09 | 12 | 103 | 5 | CID000129486 | |
| Drug | Deposiston | 1.97e-09 | 5 | 103 | 4 | CID003080829 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 1.97e-09 | 5 | 103 | 4 | CID010358258 | |
| Drug | lunularic acid | 1.97e-09 | 5 | 103 | 4 | CID000161413 | |
| Drug | himachalene | 1.97e-09 | 5 | 103 | 4 | CID000015095 | |
| Drug | actinidine | 1.97e-09 | 5 | 103 | 4 | CID000068231 | |
| Drug | 2TAA | 1.97e-09 | 5 | 103 | 4 | CID000127374 | |
| Drug | cimicifugic acid A | 1.97e-09 | 5 | 103 | 4 | CID006449879 | |
| Drug | silver perchlorate | 1.97e-09 | 5 | 103 | 4 | CID000024562 | |
| Drug | AC1L4DZ4 | 1.97e-09 | 5 | 103 | 4 | CID000155287 | |
| Drug | pie-like | 2.15e-09 | 13 | 103 | 5 | CID000017384 | |
| Drug | methyl 1'-epiacarviosin | 2.15e-09 | 13 | 103 | 5 | CID000197426 | |
| Drug | isoacarbose | 2.15e-09 | 13 | 103 | 5 | CID000449165 | |
| Drug | Cyclodextrins | 3.33e-09 | 14 | 103 | 5 | CID000024238 | |
| Drug | 2-chloro-4-nitrophenol | 3.33e-09 | 14 | 103 | 5 | CID000012074 | |
| Drug | terephthaloyl chloride | 3.33e-09 | 14 | 103 | 5 | CID000007488 | |
| Drug | 4-nitrophenylmaltoheptaoside | 4.98e-09 | 15 | 103 | 5 | CID000173254 | |
| Drug | 2-amino-6-picoline | 5.88e-09 | 6 | 103 | 4 | CID000015765 | |
| Drug | phenol blue | 5.88e-09 | 6 | 103 | 4 | CID000075078 | |
| Drug | Gu-4 | 5.88e-09 | 6 | 103 | 4 | CID000448679 | |
| Drug | Borane dimethylamine complex | 5.88e-09 | 6 | 103 | 4 | CID009898794 | |
| Drug | AC1L3OV4 | 5.88e-09 | 6 | 103 | 4 | CID000092801 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 5.88e-09 | 6 | 103 | 4 | CID009577343 | |
| Drug | AC1OAGH8 | 5.88e-09 | 6 | 103 | 4 | CID006857368 | |
| Drug | vermella | 5.88e-09 | 6 | 103 | 4 | CID000203726 | |
| Drug | hymenin | 5.88e-09 | 6 | 103 | 4 | CID000010499 | |
| Drug | mercuric thiocyanate | 5.88e-09 | 6 | 103 | 4 | CID000011615 | |
| Drug | gamma-cyclodextrin | 7.21e-09 | 16 | 103 | 5 | CID000086575 | |
| Drug | Bay e 4609 | 7.21e-09 | 16 | 103 | 5 | CID003085308 | |
| Drug | potassium periodate | 7.21e-09 | 16 | 103 | 5 | CID000516896 | |
| Drug | PNPC | 1.08e-08 | 35 | 103 | 6 | CID000165125 | |
| Drug | methyl blue | 1.37e-08 | 7 | 103 | 4 | CID011969534 | |
| Drug | 3KBG5CNP | 1.37e-08 | 7 | 103 | 4 | CID003083250 | |
| Drug | AC1L9UU3 | 1.37e-08 | 7 | 103 | 4 | CID000071762 | |
| Drug | Paramax | 1.37e-08 | 7 | 103 | 4 | CID000156411 | |
| Drug | amino-methyl | 1.37e-08 | 7 | 103 | 4 | CID000142005 | |
| Drug | trimitan | 1.40e-08 | 18 | 103 | 5 | CID000005561 | |
| Drug | aprophen | 1.40e-08 | 18 | 103 | 5 | CID000071128 | |
| Drug | boric acid gel | 2.73e-08 | 8 | 103 | 4 | CID003016474 | |
| Drug | AC1NSVJM | 2.73e-08 | 8 | 103 | 4 | CID005317411 | |
| Drug | N-vinylcaprolactam | 2.73e-08 | 8 | 103 | 4 | CID000075227 | |
| Drug | 9-azidoacridine | 2.73e-08 | 8 | 103 | 4 | CID000146692 | |
| Drug | acrinor | 2.73e-08 | 8 | 103 | 4 | CID005489637 | |
| Drug | NSC300622 | 2.73e-08 | 8 | 103 | 4 | CID000028426 | |
| Drug | theodrenaline | 2.73e-08 | 8 | 103 | 4 | CID000071857 | |
| Drug | rhodanile blue | 2.73e-08 | 8 | 103 | 4 | CID000073372 | |
| Drug | AC1L3XPY | 3.30e-08 | 21 | 103 | 5 | CID000124005 | |
| Drug | maltosaccharide | 4.26e-08 | 22 | 103 | 5 | CID005461034 | |
| Drug | GSAD | 4.89e-08 | 9 | 103 | 4 | CID009909127 | |
| Drug | GU-3 | 4.89e-08 | 9 | 103 | 4 | CID000448687 | |
| Drug | zingiberene | 4.89e-08 | 9 | 103 | 4 | CID000092776 | |
| Drug | Atonik | 4.89e-08 | 9 | 103 | 4 | CID000069471 | |
| Drug | H 187 | 4.89e-08 | 9 | 103 | 4 | CID000001742 | |
| Drug | mercuric nitrate | 4.89e-08 | 9 | 103 | 4 | CID000024864 | |
| Drug | Panose B | 6.82e-08 | 24 | 103 | 5 | CID000439297 | |
| Drug | NVP & EFV | 7.86e-08 | 121 | 103 | 8 | CID000492400 | |
| Drug | I ZE | 8.12e-08 | 10 | 103 | 4 | CID009549200 | |
| Drug | trans-cinnamamide | 8.12e-08 | 10 | 103 | 4 | CID000012135 | |
| Drug | CG-120 | 8.12e-08 | 10 | 103 | 4 | CID000171403 | |
| Drug | eicosa-11,14-dienoic acid | 8.12e-08 | 10 | 103 | 4 | CID000003208 | |
| Drug | UDP-pyridoxal | 8.12e-08 | 10 | 103 | 4 | CID000126789 | |
| Drug | naphthalene-1,3,6,8-tetrol | 8.12e-08 | 10 | 103 | 4 | CID000440202 | |
| Drug | CID439354 | 8.49e-08 | 25 | 103 | 5 | CID000439354 | |
| Drug | AC1N3UXZ | 8.99e-08 | 3 | 103 | 3 | CID004118625 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 9.88e-08 | 83 | 103 | 7 | CID011968896 | |
| Drug | Tempamine | 1.27e-07 | 11 | 103 | 4 | CID000550942 | |
| Drug | L-tert-leucine | 1.27e-07 | 11 | 103 | 4 | CID000164608 | |
| Drug | AMO-1618 | 1.27e-07 | 11 | 103 | 4 | CID000017103 | |
| Drug | AC1L8PXO | 1.27e-07 | 11 | 103 | 4 | CID000430710 | |
| Drug | chloroisocyanuric acid | 1.90e-07 | 12 | 103 | 4 | CID000017921 | |
| Drug | glyciphosphoramide | 1.90e-07 | 12 | 103 | 4 | CID000197092 | |
| Drug | chitosan | 1.90e-07 | 12 | 103 | 4 | CID000071853 | |
| Drug | Avenin | 1.90e-07 | 12 | 103 | 4 | CID000095924 | |
| Disease | alpha-amylase 1 measurement | 1.74e-08 | 9 | 103 | 4 | EFO_0801371 | |
| Disease | bone disease (implicated_via_orthology) | 4.11e-07 | 5 | 103 | 3 | DOID:0080001 (implicated_via_orthology) | |
| Disease | Insulin Resistance | 2.20e-06 | 60 | 103 | 5 | C0021655 | |
| Disease | Insulin Sensitivity | 2.20e-06 | 60 | 103 | 5 | C0920563 | |
| Disease | JACKSON-WEISS SYNDROME | 1.21e-05 | 2 | 103 | 2 | C0795998 | |
| Disease | FGFR2-related craniosynostosis | 1.21e-05 | 2 | 103 | 2 | cv:CN231480 | |
| Disease | PFEIFFER SYNDROME | 1.21e-05 | 2 | 103 | 2 | 101600 | |
| Disease | Cutis Gyrata Syndrome of Beare And Stevenson | 1.21e-05 | 2 | 103 | 2 | C1852406 | |
| Disease | Pfeiffer type acrocephalosyndactyly | 1.21e-05 | 2 | 103 | 2 | C2931888 | |
| Disease | Jackson-Weiss syndrome | 1.21e-05 | 2 | 103 | 2 | cv:C0795998 | |
| Disease | Jackson-Weiss syndrome (is_implicated_in) | 1.21e-05 | 2 | 103 | 2 | DOID:0111337 (is_implicated_in) | |
| Disease | Pfeiffer syndrome | 1.21e-05 | 2 | 103 | 2 | cv:C0220658 | |
| Disease | JACKSON-WEISS SYNDROME | 1.21e-05 | 2 | 103 | 2 | 123150 | |
| Disease | Pfeiffer syndrome (is_implicated_in) | 1.21e-05 | 2 | 103 | 2 | DOID:14705 (is_implicated_in) | |
| Disease | Pfeiffer syndrome (implicated_via_orthology) | 1.21e-05 | 2 | 103 | 2 | DOID:14705 (implicated_via_orthology) | |
| Disease | Craniofacial dysostosis type 1 | 3.61e-05 | 3 | 103 | 2 | C2931196 | |
| Disease | acrocephalosyndactylia (is_implicated_in) | 3.61e-05 | 3 | 103 | 2 | DOID:12960 (is_implicated_in) | |
| Disease | Pfeiffer Syndrome | 3.61e-05 | 3 | 103 | 2 | C0220658 | |
| Disease | TWIST1-related craniosynostosis | 7.21e-05 | 4 | 103 | 2 | cv:C4551902 | |
| Disease | Liver carcinoma | 7.31e-05 | 507 | 103 | 9 | C2239176 | |
| Disease | TYPE 2 DIABETES MELLITUS | 1.27e-04 | 28 | 103 | 3 | 125853 | |
| Disease | Type 2 diabetes mellitus | 1.27e-04 | 28 | 103 | 3 | cv:C0011860 | |
| Disease | cigarettes per day measurement | 1.54e-04 | 438 | 103 | 8 | EFO_0006525 | |
| Disease | respiratory system disease | 1.59e-04 | 145 | 103 | 5 | EFO_0000684 | |
| Disease | hypospadias (biomarker_via_orthology) | 1.79e-04 | 6 | 103 | 2 | DOID:10892 (biomarker_via_orthology) | |
| Disease | Malformation of cortical development | 1.79e-04 | 6 | 103 | 2 | cv:C1955869 | |
| Disease | Lissencephaly | 1.79e-04 | 6 | 103 | 2 | cv:C0266463 | |
| Disease | obsolete_red blood cell distribution width | ASXL1 DOCK8 TMPRSS6 SERTAD2 FOXA3 ZBTB24 LOXHD1 ZNRF3 CBX6 TMCC2 RP1L1 IRS2 FGFR1 TAL1 | 2.46e-04 | 1347 | 103 | 14 | EFO_0005192 |
| Disease | lithostathine-1-alpha measurement | 2.51e-04 | 7 | 103 | 2 | EFO_0801083 | |
| Disease | Craniosynostosis syndrome | 2.51e-04 | 7 | 103 | 2 | cv:C0010278 | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 3.33e-04 | 8 | 103 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | Cleft upper lip | 3.45e-04 | 39 | 103 | 3 | C0008924 | |
| Disease | FEV/FEC ratio | ASXL1 CHAF1B BACH2 SERTAD2 CPA1 HOXD3 PTPRM SKAP1 FGFR1 FGFR2 FGFR4 DMBT1 TAL1 | 3.49e-04 | 1228 | 103 | 13 | EFO_0004713 |
| Disease | amnestic disorder (implicated_via_orthology) | 4.28e-04 | 9 | 103 | 2 | DOID:10914 (implicated_via_orthology) | |
| Disease | autistic disorder (is_implicated_in) | 4.30e-04 | 42 | 103 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | mean corpuscular hemoglobin concentration | TMPRSS6 BACH2 SERTAD2 FOXA3 RNF43 ZNRF3 TMCC2 RP1L1 PRKAA1 IRS2 IQCJ-SCHIP1 TAL1 | 4.77e-04 | 1105 | 103 | 12 | EFO_0004528 |
| Disease | high grade glioma (implicated_via_orthology) | 4.93e-04 | 44 | 103 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | glioblastoma (is_marker_for) | 4.93e-04 | 44 | 103 | 3 | DOID:3068 (is_marker_for) | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 5.11e-04 | 105 | 103 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | Head and Neck Carcinoma | 5.33e-04 | 10 | 103 | 2 | C3887461 | |
| Disease | ovarian serous carcinoma | 5.62e-04 | 46 | 103 | 3 | EFO_1001516 | |
| Disease | Hereditary Diffuse Gastric Cancer | 5.82e-04 | 293 | 103 | 6 | C1708349 | |
| Disease | Stomach Neoplasms | 6.24e-04 | 297 | 103 | 6 | C0038356 | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement | 6.50e-04 | 11 | 103 | 2 | EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | Malignant neoplasm of stomach | 6.58e-04 | 300 | 103 | 6 | C0024623 | |
| Disease | Polydactyly | 7.67e-04 | 117 | 103 | 4 | C0152427 | |
| Disease | stomach carcinoma (is_implicated_in) | 7.78e-04 | 12 | 103 | 2 | DOID:5517 (is_implicated_in) | |
| Disease | Eczema | 7.80e-04 | 310 | 103 | 6 | HP_0000964 | |
| Disease | ferritin measurement | 8.17e-04 | 119 | 103 | 4 | EFO_0004459 | |
| Disease | drug use measurement, depressive symptom measurement, SSRI use measurement | 9.18e-04 | 13 | 103 | 2 | EFO_0007006, EFO_0007010, EFO_0007011 | |
| Disease | response to peritoneal dialysis, peritoneal solute transfer rate | 1.23e-03 | 15 | 103 | 2 | EFO_0600089, EFO_0600090 | |
| Disease | Rhabdomyosarcoma | 1.23e-03 | 15 | 103 | 2 | C0035412 | |
| Disease | Synostotic Posterior Plagiocephaly | 1.40e-03 | 16 | 103 | 2 | C1833340 | |
| Disease | Craniosynostosis, Type 1 | 1.40e-03 | 16 | 103 | 2 | C4551902 | |
| Disease | Acrocephaly | 1.40e-03 | 16 | 103 | 2 | C0030044 | |
| Disease | Trigonocephaly | 1.40e-03 | 16 | 103 | 2 | C0265535 | |
| Disease | Scaphycephaly | 1.40e-03 | 16 | 103 | 2 | C0265534 | |
| Disease | Synostotic Anterior Plagiocephaly | 1.40e-03 | 16 | 103 | 2 | C2931150 | |
| Disease | Metopic synostosis | 1.40e-03 | 16 | 103 | 2 | C1860819 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 1.54e-03 | 65 | 103 | 3 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | Brachycephaly | 1.59e-03 | 17 | 103 | 2 | C0221356 | |
| Disease | Limb Deformities, Congenital | 1.59e-03 | 17 | 103 | 2 | C0206762 | |
| Disease | Malignant neoplasm of endometrium | 1.78e-03 | 18 | 103 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 1.78e-03 | 18 | 103 | 2 | C0346191 | |
| Disease | Mental Depression | 2.00e-03 | 254 | 103 | 5 | C0011570 | |
| Disease | Drugs used in diabetes use measurement | 2.04e-03 | 255 | 103 | 5 | EFO_0009924 | |
| Disease | p-tau measurement | 2.07e-03 | 72 | 103 | 3 | EFO_0004763 | |
| Disease | Endometrial Carcinoma | 2.07e-03 | 72 | 103 | 3 | C0476089 | |
| Disease | Craniosynostosis | 2.20e-03 | 20 | 103 | 2 | C0010278 | |
| Disease | citrulline measurement | 2.20e-03 | 20 | 103 | 2 | EFO_0009777 | |
| Disease | prostate cancer (is_marker_for) | 2.21e-03 | 156 | 103 | 4 | DOID:10283 (is_marker_for) | |
| Disease | Autistic Disorder | 2.26e-03 | 261 | 103 | 5 | C0004352 | |
| Disease | Disproportionate short stature | 2.51e-03 | 77 | 103 | 3 | C0878659 | |
| Disease | osteoporosis (biomarker_via_orthology) | 2.66e-03 | 22 | 103 | 2 | DOID:11476 (biomarker_via_orthology) | |
| Disease | hematocrit | 2.84e-03 | 1011 | 103 | 10 | EFO_0004348 | |
| Disease | Cleft Palate | 2.89e-03 | 81 | 103 | 3 | C0008925 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 3.08e-03 | 171 | 103 | 4 | DOID:9352 (is_implicated_in) | |
| Disease | Intrahepatic Cholangiocarcinoma | 3.17e-03 | 24 | 103 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 3.17e-03 | 24 | 103 | 2 | C3805278 | |
| Disease | pancreatic carcinoma | 3.28e-03 | 174 | 103 | 4 | EFO_0002618 | |
| Disease | serum iron measurement | 3.43e-03 | 86 | 103 | 3 | EFO_0006332 | |
| Disease | Involutional paraphrenia | 3.44e-03 | 25 | 103 | 2 | C1571983 | |
| Disease | Psychosis, Involutional | 3.44e-03 | 25 | 103 | 2 | C1571984 | |
| Disease | Involutional Depression | 3.44e-03 | 25 | 103 | 2 | C0011574 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YSYAEDGSGGSPCSL | 526 | Q9BYV9 | |
| FSPDRSYALAGSCDG | 556 | Q8NAA4 | |
| FSCDSGYTLSDGEPL | 891 | Q7Z408 | |
| GSSVSFSCDPGYSLR | 1231 | Q7Z408 | |
| APYDARSSGSSGCPS | 266 | O95503 | |
| ASYCLTEPGSGSDAA | 156 | Q9UKU7 | |
| FGLSGASSNPCSETY | 261 | P15085 | |
| FGPYSPSGGDASSTC | 761 | P22455 | |
| TSSTCGSYFNPGSRD | 126 | P0DTE7 | |
| TSSTCGSYFNPGSRD | 126 | P0DTE8 | |
| SDGAFLAISSTDGYC | 356 | Q13112 | |
| TSSTCGSYFNPGSRD | 126 | P0DUB6 | |
| TSSTCGSYFNPGSRD | 126 | P19961 | |
| EACYSGTSTPSFHGS | 386 | Q9NUG4 | |
| TVPSRGGSDSNGSYC | 961 | Q8IXJ9 | |
| PRSAYSSDDSGCEGA | 161 | Q99929 | |
| DFSNPSACSDIYGES | 436 | Q7Z5L2 | |
| SSGSDYYGSPCSAPS | 126 | P22736 | |
| TSSTCGSYFNPGSRD | 126 | P04746 | |
| GPSDAGTYSCAVGTA | 1691 | O75147 | |
| PSYPDTRSSCSSGDD | 781 | P21802 | |
| SSSACYALATDLPGG | 711 | Q96RG2 | |
| FLLTTGDYTCASDGG | 576 | Q96PR1 | |
| ASCFYSDKDLSGASP | 76 | P31267 | |
| SGAYDFPHCQGSSSA | 571 | Q16787 | |
| PGEASSGLYSCVASS | 1686 | Q8NDA2 | |
| SGLYSCVASSPAGEA | 1691 | Q8NDA2 | |
| GPSHYSSNSEGSCSV | 3681 | Q2LD37 | |
| YTGDRSSNCSSPADF | 1376 | Q8IVV2 | |
| CASSAPYSSGSLPSD | 331 | Q9H5P4 | |
| SCDGNASDSSYRTPG | 146 | Q96M96 | |
| APSSLGTGYFCDSDS | 211 | Q8WXX7 | |
| LPSASGSFRYGSSCE | 381 | P16581 | |
| FAYDCEASFPGISTG | 166 | P07942 | |
| TSFCGYPSFSISGTC | 6 | Q9BYS1 | |
| VVGFKGCSSSSSYPA | 76 | Q6UWN0 | |
| PNGYAFTTGSDDATC | 236 | P62879 | |
| PNGYAFATGSDDATC | 236 | Q9HAV0 | |
| SVSSSKGAFLYEPCG | 441 | Q9NSB4 | |
| ASSLDTDYPGSACSI | 56 | P31249 | |
| EYPILSSGDSGTCSA | 11 | P49639 | |
| SSGDSGTCSARAYPS | 16 | P49639 | |
| ISSDEYGSSPCDFRS | 426 | P35568 | |
| SPVGDSNTSSPSDCY | 736 | P35568 | |
| SNTSSPSDCYYGPED | 741 | P35568 | |
| CLESGASFLDSPGYS | 811 | A7KAX9 | |
| SSSSYYSPDGALCDV | 1656 | A7KAX9 | |
| SCDDGLFSYDSLDSP | 506 | Q8IVE3 | |
| PTPSSSYFGGVDCSS | 236 | P32242 | |
| FSIGSGSCRFSYSDP | 266 | P78509 | |
| CSSGASGSLFYVSSD | 121 | A2A3N6 | |
| SSYSACAAIGTGSPS | 776 | Q6ZMV5 | |
| PSSSAESSVKGDFYC | 376 | Q16821 | |
| PGDYDSGSRCSSSPS | 6 | P53539 | |
| DEYGSSPGDLRAFCS | 501 | Q9Y4H2 | |
| GGFTASYTSSEDAVC | 2556 | O60494 | |
| SYTSSEDAVCGGSLP | 2561 | O60494 | |
| SLNSGSASDGYCPRE | 926 | O95996 | |
| SYYCSGSSDAPSSPA | 936 | Q8NF50 | |
| STLASFSEPGSCYEE | 421 | O43497 | |
| AFTCYAALGSDTGGS | 181 | Q9H0R6 | |
| SGLYACVTSSPSGSD | 96 | P11362 | |
| AAAAAASGFAYPGTS | 66 | P35453 | |
| SSLPAFYPGTSGSCS | 26 | Q9UBK5 | |
| PCQTTYSGSLGFGSS | 91 | Q8IUC0 | |
| YDTCFSDGSSGSPVF | 641 | Q6SJ93 | |
| YSCGGFLSQPSGDFS | 2006 | Q9UGM3 | |
| ETFSGGCLFDEPYST | 21 | P28827 | |
| TGSPSSANAGYCASL | 126 | P48304 | |
| TGISDCYGADPAFSL | 256 | A6NHM9 | |
| NTYCSAPADGSSSEL | 541 | O75529 | |
| CSVSFSNPEGYIDSS | 281 | Q9BYH1 | |
| SGASSAFLGFSYAPE | 346 | Q9HBY8 | |
| PKYGSDDECSSASAS | 471 | O75069 | |
| GGSPSDFYLCSLLAS | 331 | Q8WUG5 | |
| FFDDGPGIYTSCSKS | 271 | P0DPB3 | |
| CGSSLDGAASPDSYT | 291 | P17542 | |
| LDCGSPASSTPYFTG | 271 | P55318 | |
| PDSSGSGESYCTERS | 441 | Q68DV7 | |
| SFFDDGPGIYTSCSK | 346 | B3KU38 | |
| LSGCYPLASGSSTAE | 281 | Q8N4L4 | |
| CSDAAGAPAYSFSIS | 846 | P36956 | |
| SDGEFLRTSCGSPNY | 176 | Q13131 | |
| VTGYSFASDGDSGTC | 416 | P35611 | |
| SFYSTGSQLTPDRCG | 216 | P51449 | |
| SCGDGLNYGSSLPSS | 866 | O75970 | |
| CQDGSVPRYSGSSSS | 696 | Q8IWN7 | |
| SFCDGPSTSTGFSFG | 1186 | Q12816 | |
| SGFFPYCSFTNGETS | 251 | P35398 | |
| YDFDPCTSSSGTASK | 256 | Q14140 | |
| SPSSSNSGSYKGSDC | 226 | Q9NX95 | |
| PSTSASSGCGSDSGY | 66 | Q9Y458 | |
| DSGTDTSCVTFSYDG | 376 | Q9NW82 | |
| GSYPTFDGSSNCNSR | 231 | O94885 | |
| ETYGCDYSTSGLSFD | 461 | Q9H0V1 | |
| LAFDAICYSAGPSGD | 271 | Q9BZ71 | |
| ICYSAGPSGDSPASS | 276 | Q9BZ71 | |
| TGSHCSSEYAASSPG | 511 | P54278 | |
| PYSCGICGKSFSDSS | 461 | O43167 | |
| EYLHSSSCVDSFGSP | 606 | Q9H582 | |
| CPAPSYEEGSHSDSS | 376 | Q9NS56 | |
| GYLADCPGSDSSSSS | 541 | Q9ULT6 | |
| ACSFRGSGSPSYSLE | 61 | Q96N03 | |
| SSYDAPAGNSFLEDC | 86 | Q96BW1 | |
| FDAGDYSLLCSGPSE | 241 | Q9Y4E6 | |
| TDPSCTAFGSFNSLG | 526 | O95185 | |
| SDCETDGYLSSSGFL | 581 | Q96J92 | |
| FSPGDSYASDAASGL | 636 | Q96J92 | |
| TYDDIDGFDSPSCGS | 231 | Q86WV1 | |
| NSSSVYSFGEGPLTC | 136 | Q8IU80 | |
| SSGFSGFCASPIEES | 41 | Q8N7M2 | |
| TCTASGDPHYLTFDG | 1541 | Q9Y493 | |
| ADSPDGFFLGSCSSL | 321 | Q8N5Q1 | |
| GGDFTSPDASASSCG | 366 | Q9ULJ8 |